BRIEF published on 02/24/2026 at 08:50, 8 months 2 days ago Boiron et Panaxia s'associent dans le cannabis médical Partenariat Europe Cannabis Médical BOIRON Panaxia Malta
PRESS RELEASE published on 02/24/2026 at 08:45, 8 months 2 days ago Partenariat avec la société Panaxia Malta dans le domaine du cannabis à usage médical Les Laboratoires Boiron renforcent leur partenariat avec Panaxia Malta pour le développement du cannabis médical en Europe Partenariat Europe Cannabis Médical Laboratoires BOIRON Panaxia Malta
BRIEF published on 02/10/2026 at 10:45, 8 months 16 days ago BOIRON: Declaration of Voting Rights as of January 31, 2026 Share Capital Voting Rights Actions AMF BOIRON
BRIEF published on 02/10/2026 at 10:45, 8 months 16 days ago BOIRON : Déclaration des Droits de Vote au 31 Janvier 2026 Droits De Vote Capital Social Actions AMF BOIRON
PRESS RELEASE published on 02/10/2026 at 10:40, 8 months 16 days ago Déclaration des droits de vote au 31 janvier 2026 Publication du nombre d'actions et de droits de vote au 31 janvier 2026 selon la réglementation en vigueur Capital Droits De Vote Actions AMF Publication
BRIEF published on 01/14/2026 at 10:50, 9 months 12 days ago BOIRON: Eligibility for PEA-PME Confirmed PEA-PME Investors Market Capitalization Eligibility BOIRON
BRIEF published on 01/14/2026 at 10:50, 9 months 12 days ago BOIRON : Éligibilité au PEA-PME Confirmée PEA-PME Investisseurs Capitalisation Boursière Éligibilité BOIRON
PRESS RELEASE published on 01/14/2026 at 10:45, 9 months 12 days ago ÉLIGIBILITÉ DES TITRES BOIRON AU PEA-PME Les Laboratoires BOIRON confirment l'éligibilité de leurs titres au PEA-PME, conformément aux critères du Code monétaire et financier. Les titres BOIRON (FR0000061129 BOI) peuvent être intégrés aux comptes PEA-PME PEA-PME Titres Éligibilité Code Monétaire Et Financier Laboratoires BOIRON
BRIEF published on 01/09/2026 at 16:35, 9 months 16 days ago Publication des droits de vote de Boiron au 31 décembre 2025 Capital Droits De Vote Actions AMF BOIRON
BRIEF published on 01/09/2026 at 16:35, 9 months 16 days ago Publication of Boiron's voting rights as of December 31, 2025 Voting Rights Capital Actions AMF BOIRON
Published on 10/26/2026 at 11:00, 21 minutes ago Troubadour Resources Announces Amended Pricing of Previously Announced Non-Brokered Private Placements
Published on 10/24/2026 at 00:04, 2 days 11 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 11 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 13 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/26/2026 at 11:00, 21 minutes ago Original-Research: Yggdrasil SPAC 1 AG (to be renamed Innok Robotics Group AG) (von GBC AG): BUY
Published on 10/26/2026 at 11:00, 21 minutes ago AL-S Pharma Reports New AP-101 Phase 2 Weight Data and Outlines Phase 3 Clinical Trial in ALS at 2026 NEALS Annual Meeting
Published on 10/26/2026 at 10:30, 51 minutes ago Bronwyn Brophy O’Connor to become CEO of Carl Zeiss Meditec Group in December 2026
Published on 10/26/2026 at 10:23, 57 minutes ago Nahverkehr Schwerin updates IT system and vehicle technology with IVU solutions
Published on 10/26/2026 at 07:30, 3 hours 51 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/26/2026 at 07:30, 3 hours 51 minutes ago LE CONSEIL DE SURVEILLANCE D’EURAZEO NOMME M. CHRISTOPHE BAVIERE PRESIDENT DU DIRECTOIRE
Published on 10/23/2026 at 20:33, 2 days 14 hours ago Déclaration hebdomadaire d'opérations effectuées du 19 au 23 octobre 2026
Published on 10/23/2026 at 20:33, 2 days 14 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 17 hours ago Imerys-10-2026-communique-capital-droits-de-vote-au-30-septembre-2026
